0.59
0.02 (3.51%)
0.02 (3.51%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0006 | 0.11% | 0.57 | 0.55 | 0.5796 | 0.564 | 0.5694 | 00:00:01 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.56 | 0.649 | 0.089 | 13.71% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 674 | 320,749 | $ 0.5615677 | $ 180,122 | 1,986,451 | 0.323 - 3.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:48:57 | formt | 100 | $ 0.59 | USD |
Moleculin Biotech Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 30.34M | 53.23M | $ -11.88M | -0.34 | - | 51.78M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.63 | 0.67 | 0.54 | 0.5780946 | 823,166 | -0.06 | -9.52% |
| 1 Month | 0.65 | 1.62 | 0.323 | 0.5903492 | 2,763,900 | -0.08 | -12.31% |
| 3 Months | 0.96 | 1.62 | 0.323 | 0.7022185 | 1,560,734 | -0.39 | -40.63% |
| 6 Months | 1.02 | 1.62 | 0.323 | 0.7468345 | 837,806 | -0.45 | -44.12% |
| 1 Year | 0.961 | 3.15 | 0.323 | 1.57 | 1,369,876 | -0.391 | -40.69% |
| 3 Years | 1.07 | 3.75 | 0.323 | 1.85 | 973,554 | -0.50 | -46.73% |
| 5 Years | 8.99 | 9.58 | 0.323 | 1.86 | 832,970 | -8.42 | -93.66% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis. |
